The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhu, L.
Right arrow Articles by Anasetti, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhu, L.
Right arrow Articles by Anasetti, C.

The Journal of Immunology, Vol 154, Issue 1 192-200, Copyright © 1995 by American Association of Immunologists


ARTICLES

Cell cycle control of apoptosis in human leukemic T cells

L Zhu and C Anasetti
Human Immunogenetics Program, Fred Hutchinson Cancer Research Center, Seattle, WA 98104.

Eukaryotic cell cycle is regulated by feedback controls that can arrest the progress of the cell cycle at specific checkpoints. Failure of feedback controls may predispose cells to undergo apoptotic death in response to a variety of stimuli. Transformed cell lines often carry defects in one or more proteins that regulate cell cycle, and therefore can be used as a model to study how cell cycle controls cell death. The present study investigated whether TCR/CD3-induced apoptosis of human leukemic T cells is cell cycle dependent. Studies of Jurkat and Sup- T13, two human leukemic T cell lines, demonstrated that anti-CD3 Ab- driven activation results in a transient, reversible inhibition of DNA synthesis in Jurkat cells, but results in a persistent, irreversible inhibition of DNA synthesis in Sup-T13 cells. Anti-CD3 mAb blocked Jurkat cells at the G1/S interface without inducing cell death. In contrast, anti-CD3 mAb allowed Sup-T13 cells to enter S phase but inhibited progression into G2 phase and triggered cell death. Electron microscopy showed that anti-CD3 mAb-stimulated Sup-T13 cells acquired the characteristic morphology of apoptosis. The nuclear DNA appeared as oligonucleosome-sized fragments by gel electrophoresis, and as an apoptotic peak displaying lower fluorescence than the DNA content of cells in G1 phase by DNA flow microfluorometry. DNA fragmentation correlated with entry into S phase. The DNA synthesis inhibitor aphidicolin arrested Sup-T13 cells at the G1/S interface and prevented the apoptosis. Therefore, DNA synthesis is required for executing the apoptosis program initiated by TCR/CD3 stimulation of Sup-T13 cells. These data are consistent with the hypothesis that the suicide of activated cycling T cells upon encountering autoantigens may be one of the mechanisms for the immune system to prevent autoimmunity.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
R. Torgler, S. Jakob, E. Ontsouka, U. Nachbur, C. Mueller, D. R. Green, and T. Brunner
Regulation of Activation-induced Fas (CD95/Apo-1) Ligand Expression in T Cells by the Cyclin B1/Cdk1 Complex
J. Biol. Chem., September 3, 2004; 279(36): 37334 - 37342.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C.-J. Chen and S. Makino
Murine Coronavirus Replication Induces Cell Cycle Arrest in G0/G1 Phase
J. Virol., June 1, 2004; 78(11): 5658 - 5669.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. A. Carpenter, S. Pavlovic, J. Y. Tso, O. W. Press, T. Gooley, X.-Z. Yu, and C. Anasetti
Non-Fc Receptor-Binding Humanized Anti-CD3 Antibodies Induce Apoptosis of Activated Human T Cells
J. Immunol., December 1, 2000; 165(11): 6205 - 6213.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Xaus, M. Comalada, M. Barrachina, C. Herrero, E. Gonalons, C. Soler, J. Lloberas, and A. Celada
The Expression of MHC Class II Genes in Macrophages Is Cell Cycle Dependent
J. Immunol., December 1, 2000; 165(11): 6364 - 6371.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. J. J. C. Boonen, B. A. van Oirschot, A. van Diepen, W. J. M. Mackus, L. F. Verdonck, G. Rijksen, and R. H. Medema
Cyclin D3 Regulates Proliferation and Apoptosis of Leukemic T Cell Lines
J. Biol. Chem., December 3, 1999; 274(49): 34676 - 34682.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
M. Karas, T. Z. Zaks, L. JL, and D. LeRoith
T Cell Receptor-induced Activation and Apoptosis In Cycling Human T Cells Occur throughout the Cell Cycle
Mol. Biol. Cell, December 1, 1999; 10(12): 4441 - 4450.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
A. Allione, P. Bernabei, M. Bosticardo, S. Ariotti, G. Forni, and F. Novelli
Nitric Oxide Suppresses Human T Lymphocyte Proliferation Through IFN-{gamma}-Dependent and IFN-{gamma}-Independent Induction of Apoptosis
J. Immunol., October 15, 1999; 163(8): 4182 - 4191.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Allione, V. Wells, G. Forni, L. Mallucci, and F. Novelli
{beta}-Galactoside-Binding Protein ({beta}GBP) Alters the Cell Cycle, Up-Regulates Expression of the {alpha}- and {beta}-Chains of the IFN-{gamma} Receptor, and Triggers IFN-{gamma}-Mediated Apoptosis of Activated Human T Lymphocytes
J. Immunol., September 1, 1998; 161(5): 2114 - 2119.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. Morra, M. Zubiaur, C. Terhorst, J. Sancho, and F. Malavasi
CD38 is functionally dependent on the TCR/CD3 complex in human T cells
FASEB J, May 1, 1998; 12(7): 581 - 592.
[Abstract] [Full Text]


Home page
DevelopmentHome page
S. Rehen, M. Varella, F. Freitas, M. Moraes, and R Linden
Contrasting effects of protein synthesis inhibition and of cyclic AMP on apoptosis in the developing retina
Development, January 5, 1996; 122(5): 1439 - 1448.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.